Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Kinetics of response of cytomegalovirus with ganciclovir treatment using quantitative real-time PCR Clinical Trials Info presented on Clinical Trials Search is not intended to be a substitute for certified medical advice, visits or professional assistance using a real physician. We are not physicians. Always consult your dr. about Kinetics of response of cytomegalovirus with ganciclovir treatment using quantitative real-time PCR conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Kinetics of response of cytomegalovirus with ganciclovir treatment using quantitative real-time PCR Clinical research trials and Kinetics of response of cytomegalovirus with ganciclovir treatment using quantitative real-time PCR health trials happen in many of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new drugs. The function of the studies / projects is to resolve particular human medical questions. Clinical trials are a popular manner for mDs, government agencies, and private sector corporations to discover remedies for all varieties of circumstances, like Kinetics of response of cytomegalovirus with ganciclovir treatment using quantitative real-time PCR. Kinetics of response of cytomegalovirus with ganciclovir treatment using quantitative real-time PCR Clinical Trials and other clinical trials allow volunteers to obtain healthcare treatment options before they are available to the masses. Some times the participants undergo professional assistance for free of charge, and occasionally they are paid for their time. Sometimes there is a cost for a Kinetics of response of cytomegalovirus with ganciclovir treatment using quantitative real-time PCR clinical trial. Human subjects often get the best healthcare available for their Kinetics of response of cytomegalovirus with ganciclovir treatment using quantitative real-time PCR condition. Dangers are a reality, however, and may include additional or frequent mD visits, healthcare dangers (potentially life-jeopardising), and/or the treatment being ineffectual. Trials are federally governed with rigorous guidelines to protect clinical trials patients.

Home > "K" Clinical Trials Conditions > Kinetics of response of cytomegalovirus with ganciclovir treatment using quantitative real-time PCR

Kinetics of response of cytomegalovirus with ganciclovir treatment using quantitative real-time PCR



Kinetics of response of cytomegalovirus with ganciclovir treatment using quantitative real-time PCR

For Condition: Cytomegalovirus Infections
Status: No longer recruiting
Sponsor(s): National Center for Research Resources (NCRR) ,
Synopsis: The overall purpose of this research is to develop and use a blood test to better understand how quickly the viral drug ganciclovir works to clear infection with the CMV virus (Cytomegalovirus) when it occurs. This test will potentially let doctors know early in the course of therapy when a virus is not responding well to the therapy and could therefore be resistant to the drug. The target population of this study will be primarily kidney and lung transplant patients with CMV detected in the blood, although other patients may also be included if they meet criteria. The study will be divided into two phases. Phase I will evaluate a small number of exploratory patients initiating ganciclovir therapy and will require frequent blood sampling to obtain detailed information regarding the kinetic response of the virus to therapy. This information will be analyzed to help guide decisions regarding the number and frequency of blood samples needed in the larger phase II portion of the study. Strains will be characterized using phenotypic and genotypic methods to determine the presence or absence of mutations potentially responsible for the resistance.
Details:
Eligibility:
Study Type:
  Interventional, Diagnostic
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Patients affiliated with Barnes-Jewish Hospital with CMV blood infection requiring antiviral therapy - All patients will have a positive qualitative CMV PCR or viral culture before starting therapy - Patients will receive treatment with ganciclovir at a dose and duration to be determined by the provider - It is anticipated that most subjects will be organ transplant recipients but this is not a requirement of the study Exclusion Criteria: - Critically ill patients - Patients with profound leukopenia or abnormal renal function that make a change in the antiviral drug dosage likely during the duration of the study - Anemia (HGB < 8 g/dl) that would contraindicate the extra blood draws required by this study - Problems with vascular access that would interfere with obtaining blood samples required by this study - Residence outside of the St. Louis metropolitan area during the period of ganciclovir therapy - Patients who are unable to provide informed consent because of diminished capacity related to illness, dementia, or other reasons
Total Enrollment: 

Location and Contact Information:

Infectious Diseases Division
St. Louis,  Missouri,  63110
United States
 


Additional Information:
Study ID Numbers:
  NCRR-M01RR00036-0728;  M01RR00036
Study Start Date: 
Record last reviewed: November 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004573

Other Cytomegalovirus Infections Studies:
1. Assessment of valganciclovir in neonates with CMV

2. A Study of Lobucavir in Patients with AIDS

3. A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria

4. Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women with Chronic Infections

5. Transfusion Infections Pediatric Prospective Study (TRIPPS)

Related Studies:

Other Cytomegalovirus Infections Clinical Trials
Other Missouri Clinical Trials
Other St. Louis Clinical Trials

Kinetics of response of cytomegalovirus with ganciclovir treatment using quantitative real-time PCR

Modify your Search

  Other Cytomegalovirus Infections Clinical Trials
  Other Missouri Clinical Trials
  Other St. Louis Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103